Home / Japan / Delta-Fly Pharma,Inc.
Delta-Fly Pharma,Inc.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
2 disclosures on record
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 4, 2026 | Barclays Capital Securities Ltd | 0.36% | still open |
| August 3, 2026 | Nomura International plc | 0.72% | still open |
Other companies sold short in Japan
- ReYuu Japan Inc. 14.89% of the capital sold short
- KLab Inc. 14.77% of the capital sold short
- Sanrio Company,Ltd. 14.04% of the capital sold short
- eole Inc. 12.76% of the capital sold short
- Renascience Inc. 12.01% of the capital sold short
- Jibannet Holdings Co.,Ltd. 11.49% of the capital sold short
- Unitika LTD. 10.78% of the capital sold short
- Hokkaido Electric Power Company,Incorporated 10.17% of the capital sold short
- 3-D Matrix,Ltd. 10.04% of the capital sold short
- QD Laser,Inc. 10.00% of the capital sold short
- Terra Drone Corporation 9.69% of the capital sold short
- Nomura Micro Science Co.,Ltd. 8.34% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Delta-Fly Pharma,Inc., source JPX, data as at August 4, 2026, https://www.quivad.com/action/delta-fly-pharma-inc